On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Zeclinics SL's own share of each project, not the project's full budget.
- Horizon 2020€3.0M · 7 projects
- Horizon Europe€986k · 4 projects
Projects
11 EU-funded projects, newest first. Zeclinics SL led 2 of them as coordinator. Each links to the official record.
- Cilia-AIAssociated partner
European Training Program for Deconvolution of Multi-scale Cilia Function in Health and Disease by Integrating Machine Learning-AI Approaches.
Horizon Europe · 2025–2029 · Project on CORDIS ↗
- REGENERATE-ITAssociated partner
Learning from animals how to regenerate: multidisciplinary training programme in regenerative biology
Horizon Europe · 2023–2027 · Project on CORDIS ↗
- CarrerasLeadersAssociated partner
Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers
Horizon Europe · 2023–2028 · Project on CORDIS ↗
- EdiGenTPartner
New Prime Editing and non-viral delivery strategies for Gene Therapy
Horizon Europe · 2022–2027 · Project on CORDIS ↗
€986ktheir share - SCilSPartner
Studying Ciliary Signaling in Development and Disease
Horizon 2020 · 2020–2024 · Project on CORDIS ↗
€251ktheir share - VIDECPartner
Visualizing Death Inducing Protein Complexes
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€184ktheir share - REANIMAPartner
New-generation cardiac therapeutic strategies directed to the activation of endogenous regenerative mechanisms
Horizon 2020 · 2020–2025 · Project on CORDIS ↗
€250ktheir share - ZENITHPartner
ZEbrafish Neuroscience Interdisciplinary Training Hub
Horizon 2020 · 2019–2024 · Project on CORDIS ↗
€251ktheir share - ZeNewCardioCoordinator
ZeNewCardio: Discovering Heart Regeneration Therapies Through Zebrafish
Horizon 2020 · 2019–2021 · Project on CORDIS ↗
€161ktheir share - ZECARDIOCoordinator
Cardiotoxicity High-throughput screening (HTS) with zebrafish embryo
Horizon 2020 · 2017–2019 · Project on CORDIS ↗
€1.9Mtheir share - 3D NEONETPartner
Drug Discovery and Delivery NEtwork for ONcology and Eye Therapeutics
Horizon 2020 · 2017–2022 · Project on CORDIS ↗
€9ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Max-Planck-Gesellschaft zur Forderung der Wissenschaften eVGermany · 3 shared projects
- Kobenhavns UniversitetDenmark · 3 shared projects
- Imagine Institut des Maladies Genetiques Necker Enfants Malades FondationFrance · 3 shared projects
- Institut National de la Sante et de la Recherche MedicaleFrance · 2 shared projects
- Aarhus UniversitetDenmark · 2 shared projects
- The University of EdinburghUnited Kingdom · 2 shared projects
- Stichting Radboud UniversiteitNetherlands · 2 shared projects
- Universitat WienAustria · 2 shared projects
- Rijksuniversiteit GroningenNetherlands · 2 shared projects
- Eberhard Karls Universitaet TuebingenGermany · 2 shared projects
- Charite - Universitaetsmedizin BerlinGermany · 2 shared projects
- Ruprecht-Karls-Universitaet HeidelbergGermany · 2 shared projects
- Universidad Pompeu FabraSpain · 2 shared projects
- University of GalwayIreland · 2 shared projects
- Stichting Radboud Universitair Medisch CentrumNetherlands · 2 shared projects
- Sorbonne UniversiteFrance · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- automation
- breast cancer
- cardiology
- cardiovascular diseases
- computational science
- drug discovery
- embryology
- fisheries
- gene therapy
- genetics
- homeostasis
- invertebrate zoology
- machine learning
- mammalogy
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
